MedTrace Logo

Preventive Nutritional Supplements for Preclinical Pathologies

NCT07265115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2026-04-28

No results posted yet for this study

Summary

The main objective of this intervention study was to evaluate the functionality of a multi-target preparation (rich in phloretin from apple, chromium picolinate, zinc, magnesium and cinnamon extract) on the glucose response of individuals who show factors associated with prediabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Capsules with microcrystalline cellulose 102

DIETARY_SUPPLEMENT

Capsules with active ingredients

Capsules with phloretin rich apple extract, magnesium oxide, cinnamon extract, zinc citrate and chromium picolinate

DIETARY_SUPPLEMENT

Placebo Repetition

Repetition of the placebo (capsules with microcrystalline cellulose 102) intake

DIETARY_SUPPLEMENT

Capsules with active ingredients Repetition

Repetition of the supplement intake (Capsules with phloretin rich apple extract, magnesium oxide, cinnamon extract, zinc citrate and chromium picolinate)

Sponsors & Collaborators

  • San Antonio Technologies - San Antonio Catholic University of Murcia

    collaborator OTHER

  • Centro de Edafología y Biología Aplicada del Segura

    lead OTHER_GOV

Principal Investigators

  • Francisco A Tomás-Barberán, PhD · CEBAS-CSIC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-12
Primary Completion
2026-02-10
Completion
2026-02-10

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07265115 on ClinicalTrials.gov